Difference between revisions of "L4E rule 7-8 (2014)"
Jump to navigation
Jump to search
(Created page with "This article covers '''L4E rule 7''' for the 2014 L4E workload system. An overview of the L4E rules is found in the L4E rules of 2014. The definitive reference f...") |
|||
Line 18: | Line 18: | ||
| All specimen types | | All specimen types | ||
| 0.33 L4E/immunostain slide | | 0.33 L4E/immunostain slide | ||
| | | does '''not''' include [[Quality#Classification_of_IHC_tests|class 2]] IHC tests (e.g. ER/PR/HER2 for breast ca), 1 IHC = 0.33 L4E, 2 IHC = 0.66 L4E, 3 IHC = 1 L4E ... | ||
| 2 lung cores with CRC demonstrated with 5 IHC = 1 L4E ([[L4E rule 1|rule 1]]) + 5 x 0.33 L4E | | 2 lung cores with CRC demonstrated with 5 IHC = 1 L4E ([[L4E rule 1|rule 1]]) + 5 x 0.33 L4E | ||
|} | |} | ||
Note: | Note: | ||
* | *[[Quality#Classification_of_IHC_tests|Class 2 IHC tests]] are covered by [[L4E rule 8 (2014)|L4E rule 8]]. | ||
==See also== | ==See also== |
Revision as of 04:42, 25 October 2017
This article covers L4E rule 7 for the 2014 L4E workload system. An overview of the L4E rules is found in the L4E rules of 2014.
The definitive reference for the rule is found on the CAP-ACP website.[1]
Overview
- This rule applies to specimens with additional stains and/or diagnostic (class 1) immunostains.
Note:
- Class 2 immunostains (e.g. ER/PR/HER2 for breast cancer) are covered by rule 8.
Details
Specimen type(s) | Weight (L4E) | Details | Examples |
---|---|---|---|
All specimen types | 0.33 L4E/immunostain slide | does not include class 2 IHC tests (e.g. ER/PR/HER2 for breast ca), 1 IHC = 0.33 L4E, 2 IHC = 0.66 L4E, 3 IHC = 1 L4E ... | 2 lung cores with CRC demonstrated with 5 IHC = 1 L4E (rule 1) + 5 x 0.33 L4E |
Note:
- Class 2 IHC tests are covered by L4E rule 8.
See also
References
- ↑ Workload and Workforce Committee of the CAP-ACP. Workload Measurement Guidelines. Canadian Association of Pathologists (CAP-ACP). 2014. URL: https://www.cap-acp.org/cmsUploads/CAP/File/CAP-ACP%202014%20Workload%20FINAL.pdf. Accessed on: 17 October 2017.